KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Assets Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.14%
Dec 31, 2025 7.55%
Sep 30, 2025 6.88%
Jun 30, 2025 6.22%
Mar 31, 2025 7.70%
Dec 31, 2024 8.99%
Sep 30, 2024 8.83%
Jun 30, 2024 8.89%
Mar 31, 2024 7.76%
Dec 31, 2023 7.90%
Sep 30, 2023 6.10%
Jun 30, 2023 5.93%
Mar 31, 2023 4.51%
Dec 31, 2022 -4.02%
Sep 30, 2022 -4.53%
Jun 30, 2022 -5.72%
Mar 31, 2022 -5.33%
Dec 31, 2021 -4.65%
Sep 30, 2021 -3.62%
Jun 30, 2021 -4.56%
Mar 31, 2021 -3.60%
Dec 31, 2020 -2.50%
Sep 30, 2020 -2.10%
Jun 30, 2020 -1.80%
Mar 31, 2020 -2.21%
Dec 31, 2019 -2.85%
Sep 30, 2019 -3.40%
Jun 30, 2019 -3.11%
Mar 31, 2019 -0.91%
Dec 31, 2018 0.09%
Sep 30, 2018 3.36%
Jun 30, 2018 5.17%
Mar 31, 2018 6.62%
Dec 31, 2017 8.05%
Sep 30, 2017 7.70%
Dec 31, 2016 9.70%
Mar 31, 2015 11.30%
Dec 31, 2014 11.73%
Sep 30, 2014 11.57%
Jun 30, 2014 12.35%